Clinical Trial Update: A Clinical Trial of PRAX-114 in Participants With Major Depressive Disorder [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for PRAX-114 in participants with Major Depressive Disorder (Phase 2/Phase 3) completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• PRAX-114 (PRAX-114)

Snippet

Sponsor: Praxis Precision Medicines | Conditions: Major Depressive Disorder | Phase 2, Phase 3 | Status: COMPLETED